Elmira Gurbanova

Time to act to prevent and control tuberculosis among inmates [Official Statement of The International Union Against Tuberculosis and Lung Disease]

Masoud Dara, Sarabjit Chadha, Natalie V. S. Vinkeles Melchers et al. · The International Journal of Tuberculosis and Lung Disease · 2012 · 28 citations

Public Health, Infectious Diseases, Preventive Medicine +16

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

Oleksandr Korotych, Jay Achar, Elmira Gurbanova et al. · The Lancet Infectious Diseases · 2024 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety of prolonged treatment with bedaquiline in programmatic conditions

Dzmitriy Zhurkin, Elmira Gurbanova, Jonathon R. Campbell et al. · ERJ Open Research · 2022 · 14 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by Xpert <i>Mycobacterium tuberculosis/</i> Rifampicin and Mycobacterium Growth Indicator Tube

Elmira Gurbanova, Rafail Mehdiyev, Kai Blöndal et al. · Microbial Drug Resistance · 2017 · 12 citations

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +16

Tuberculosis Notification Trends and Treatment Outcomes in Penitentiary and Civilian Health Care Sectors in the WHO European Region

Andrei Dadu, Ana Ciobanu, Natavan Alikhanova et al. · International Journal of Environmental Research and Public Health · 2021 · 11 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +15